Ketamine-Based Treatment of MDD: A Biologist’s Perspective
Journal Title: Journal of Depression and Therapy - Year 2017, Vol 1, Issue 3
Abstract
Ketamine’s potential as a fast-acting reagent to treat MDD, especially treatment-resistant depression has caught much attention recently. Although much has been learned about the biological mechanisms underlying ketamine’s effect, there are a few critical issues remained to be resolved. This mini review will briefly discuss several controversial issues that warrant further studies, regarding the molecular, physiological, psychopharmacological, and behavioral effects of ketamine. Understand how ketamine works as an anti-depressant will open the door to better understanding of MDD and its treatment.
Authors and Affiliations
Shupeng Li, Yingli Zhang, Qiang Zhou
A Specific Case of Non-Specificity: Longitudinal Effects of Dysfunctional Attitudes on Depressive, Eating Disorder and Aggressive Symptoms in Children and Adolescents
An important step in the validation of disorder-specific etiological models is the examination of the predictive specificity of proposed vulnerability factors. It may advance the understanding of the emergence of comorbi...
The Antidepressant-Like Activity of the New Tetrapeptide Neuroprotector Kk-1, Homologous of Acth15-18 Sequence (An Experimental Study)
The aim of study is to evaluate antidepressant-like activity of the new peptidergic neuroprotector acetyl-(D-Lys)-Lys-Arg-Arg-amide, homologous of ACTH15-18 primary amino acids sequence, that demonstrates nootropic and n...
“On the Road to A Better Life”: An Innovative Suicide Prevention Program Based on The Realization of Meaningful Personal Goals
Background. Suicide prevention programs centred on reinforcing protective factors are uncommon. Aims. Since leading a meaningful life is incompatible with suicide, a 14-week program designed to help participants realize...
Differentiating Depression from Apathy in Chronic Kidney Disease: A Prospective Study
Background. Emotional deterioration is frequently found in patients with chronic kidney disease, but some patients are affected by depressed mood without fulfilling the criteria of a depressive disorder. Those patients m...
Depression and Executive Dysfunction in Young Adults; Implications for Therapy
The prevalence of young adults endorsing depressive symptomatology is thought to peak during late adolescence. While there has been a wealth of research assessing the relationship between decline of the prefrontal corte...